Tharimmune, a clinical-stage biotech firm specializing in inflammation and immunology therapies, will present at the 2024 BIO International Convention from June 3-6 in San Diego. The company will showcase its therapeutic candidates and hold one-on-one meetings with investors and industry leaders. The presentation is scheduled for June 3 at 1:45 p.m. PT in Company Presentation Theater 3. Interested parties can arrange meetings via the BIO One-on-One Partnering system or by contacting Tirth Patel of LHA Investor Relations.
EUGENE啊梁 : Junk, 15 shares in 1 share, can slowly fall
Lambor Tan : please share where this news coming from ?
Lambor Tan : this is good news. at lease marketing the brand